Fusion to C3d Enhances the Immunogenicity of the E2 Glycoprotein of Type 2 Bovine Viral Diarrhea Virus

Journal of Virology

Volumn 78, Issue 4, 2004, Pages 1616-1622

  Wang, Lingshu ^a   Sunyer, J Oriol ^a   Bello, Leonard J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D; DNA VACCINE; GLYCOPROTEIN E2; GLYCOPROTEIN E2 COMPLEMENT COMPONENT C3D FUSION PROTEIN; HYBRID PROTEIN; LYSOZYME; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CASSETTE; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN TARGETING; VACCINATION; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CELL LINE; COMPLEMENT C3D; DIARRHEA VIRUSES, BOVINE VIRAL; FEMALE; HUMANS; IMMUNIZATION; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RECOMBINANT FUSION PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0842347779     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.4.1616-1622.2004     Document Type: Article

References (53)

1. Becher, P., M. Orlich, A. Kosmidou, M. Konig, M. Baroth, and H. J. Thiel. 1999. Genetic diversity of pestiviruses: identification of novel groups and implications for classification. Virology 262:64-71.
2. Berek, C., and M. Ziegner. 1993. The maturation of the immune response. Immunol. Today 14:400-404.
3. Berzofsky, J. A., J. D. Ahlers, and I. M. Belyakov. 2001. Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 1:209-219.
4. Bolin, S. R. 1995. Control of bovine viral diarrhea infection by use of vaccination. Vet. Clin. N. Am. Food Anim. Pract. 11:615-625.
5. Bolin, S. R., and J. F. Ridpath. 1992. Differences in virulence between two noncytopathic bovine viral diarrhea viruses in calves. Am. J. Vet. Res. 53:2157-2163.
6. Bolin, S. R., and J. F. Ridpath. 1996. Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease. Arch. Virol. 141:1463-1477.
7. Bolin, S. R., and J. F. Ridpath. 1989. Specificity of neutralizing and precipitating antibodies induced in healthy calves by monovalent modified-live bovine viral diarrhea virus vaccines. Am. J. Vet. Res. 50:817-821.
8. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149:2841-2850.
9. Bruschke, C. J., R. J. Moormann, J. T. van Oirschot, and P. A. van Rijn. 1997. A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine 15:1940-1945.
10. Bruschke, C. J., J. T. van Oirschot, and P. A. van Rijn. 1999. An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep. Vaccine 17:1983-1991.
11. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffman, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457-463.
12. Cho, H. J., K. Takabayashi, P. M. Cheng, M. D. Nguyen, M. Corr, S. Tuck. and E. Raz. 2000. Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat. Biotechnol. 18:509-514.
13. Corapi, W. V., R. D. Elliott, T. W. French, D. G. Arthur, D. M. Bezek, and E. J. Dubovi. 1990. Thrombocytopenia and hemorrhages in veal calves infected with bovine viral diarrhea virus. J. Am. Vet. Med. Assoc. 196:590-596.
14. Dempsey, P. W., M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348-350.
15. Donello, J. E., J. E. Loeb, and T. J. Hope. 1998. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J. Virol. 72:5085-5092.
16. Donis, R. O., and E. J. Dubovi. 1987. Molecular specificity of the antibody responses of cattle naturally and experimentally infected with cytopathic and noncytopathic bovine viral diarrhea virus biotypes. Am. J. Vet. Res. 48:1549-1554.
17. Fearon, D. T. 1998. The complement system and adaptive immunity. Semin. Immunol. 10:355-361.
18. Fulton, R. W., A. W. Confer, L. J. Burge, L. J. Perino, J. M. d'Offay, M. E. Payton, and R. E. Mock. 1995. Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140. Vaccine 13:725-733.
19. Fulton, R. W., J. T. Saliki, L. J. Burge, J. M. d'Offay, S. R. Bolin, R. K. Maes, J. C. Baker, and M. L. Frey. 1997. Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay. Clin. Diagn. Lab. Immunol. 4:380-383.
20. Green, T. D., D. C. Montefiori, and T. M. Ross. 2003. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J. Virol. 77:2046-2055.
21. Green, T. D., B. R. Newton, P. A. Rota, Y. Xu, H. L. Robinson, and T. M. Ross. 2001. C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 20:242-248.
22. Hamers, C., P. Dehan, B. Couvreur, C. Letellier, P. Kerkhofs, and P. P. Pastoret. 2001. Diversity among bovine pestiviruses. Vet. J. 161:112-122.
23. Harpin, S., D. J. Hurley, M. Mbikay, B. Talbot, and Y. Elazhary. 1999. Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2. J. Gen. Virol. 80:3137-3144.
24. Harpin, S., B. Talbot, M. Mbikay, and Y. Elazhary. 1997. Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2). FEMS Microbiol. Lett. 146:229-234.
25. Horzinek, M. C. 1991. Pestiviruses-taxonomic perspectives. Arch. Virol. Suppl. 3:1-5.
26. Houe, H. 1999. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet. Microbiol. 64:89-107.
27. Lawrence, W. C., R. C. D'Urso, C. A. Kundel, J. C. Whitbeck, and L. J. Bello. 1986. Map location of the gene for a 130,000-dalton glycoprotein of bovine herpesvirus 1. J. Virol. 60:405-414.
28. Lindhout, E., M. L. Mevissen, J. Kwekkeboom, J. M. Tager, and C. de Groot. 1993. Direct evidence that human follicular dendritic cells (FDC) rescue germinal centre B cells from death by apoptosis. Clin. Exp. Immunol. 91:330-336.
29. Martinez, X., X. Li, J. Kovarik, M. Klein, P. H. Lambert, and C. A. Siegrist. 1999. Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice. Eur. J. Immunol. 29:3390-3400.
30. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173:55-64.
31. Meyers, G., and H. J. Thiel. 1996. Molecular characterization of pestiviruses. Adv. Virus Res. 47:53-118.
32. Mitchell, J. A., T. D. Green, R. A. Bright, and T. M. Ross. 2003. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 21:902-914.
33. Nielsen, C. H., E. M. Fischer, and R. G. Leslie. 2000. The role of complement in the acquired immune response. Immunology 100:4-12.
34. Nielsen, C. H., and R. G. Leslie. 2002. Complement's participation in acquired immunity. J. Leukoc. Biol. 72:249-261.
35. Nobiron, I., I. Thompson, J. Brownlie, and M. E. Collins. 2000. Co-administration of IL-2 enhances antigen-specific immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhoea virus. Vet. Microbiol. 76:129-142.
36. Nobiron, I., I. Thompson, J. Brownlie, and M. E. Collins. 2001. Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice. Vaccine 19:4226-4235.
37. Nobiron, I., I. Thompson, J. Brownlie, and M. E. Collins. 2003. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine 21:2091-2101.
38. O'Rourke, K. 2002. BVDV: 40 years of effort and the disease still has a firm hold. J. Am. Vet. Med. Assoc. 220:1770-1773.
39. Pellerin, C., J. van den Hurk, J. Lecomte, and P. Tussen. 1994. Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. Virology 203:260-268.
40. Rebhun, W. C., T. W. French, J. A. Perdrizet, E. J. Dubovi, S. G. Dill, and L. F. Karcher. 1989. Thrombocytopenia associated with acute bovine virus diarrhea infection in cattle. J. Vet. Intern. Med. 3:42-46.
41. Ridpath, J. F., S. R. Bolin, and E. J. Dubovi. 1994. Segregation of bovine viral diarrhea virus into genotypes. Virology 205:66-74.
42. Ross, T. M., Y. Xu, R. A. Bright, and H. L. Robinson. 2000. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1:127-131.
43. Ross, T. M., Y. Xu, T. D. Green, D. C. Montefiori, and H. L. Robinson. 2001. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res. Hum. Retrovir. 17:829-835.
44. Shirota, H., K. Sano, N. Hirasawa, T. Terui, K. Ohuchi, T. Hattori, K. Shirato, and G. Tamura. 2001. Novel roles of CpG oligodeoxynucleotides as a leader for the sampling and presentation of CpG-tagged antigen by dendritic cells. J. Immunol. 167:66-74.
45. Shirota, H., K. Sano, T. Kikuchi, G. Tamura, and K. Shirato. 2000. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J. Immunol. 164:5575-5582.
46. Suradhat, S., R. P. Braun, P. J. Lewis, L. A. Babiuk, S. van Drunen Littelvan den Hurk, P. J. Griebel, and M. E. Baca-Estrada. 2001. Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization. Vet. Immunol. Immunopathol. 83:79-92.
47. Test, S. T., J. Mitsuyoshi, C. C. Connolly, and A. H. Lucas. 2001. Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide. Infect. Immun. 69:3031-3040.
48. van Oirschot, J. T., C. J. Bruschke, and P. A. van Rijn. 1999. Vaccination of cattle against bovine viral diarrhoea. Vet. Microbiol. 64:169-183.
49. Villiers, M. B., P. N. Marche, and C. L. Villiers. 2003. Improvement of long-lasting response and antibody affinity by the complexation of antigen with complement C3b. Int. Immunol. 15:91-95.
50. Villiers, M. B., C. L. Villiers, A. M. Laharie, and P. N. Marche. 1999. Amplification of the antibody response by C3b complexed to antigen through an ester link. J. Immunol. 162:3647-3652.
51. Villiers, M. B., C. L. Villiers, A. M. Laharie, and P. N. Marche. 1999. Different stimulating effects of complement C3b and complete Freund's adjuvant on antibody response. Immunopharmacology 42:151-157.
52. Wang, L., S. Menon, S. R. Bolin, and L. J. Bello. 2003. A hepadnavirus regulatory element enhances expression of a type 2 bovine viral diarrhea virus E2 protein from a bovine herpesvirus 1 vector. J. Virol. 77:8775-8782.
53. Wetsel, R. A., A. Lundwall, F. Davidson, T. Gibson, B. F. Tack, and G. H. Fey. 1984. Structure of murine complement component C3. II. Nucleotide sequence of cloned complementary DNA coding for the alpha chain. J. Biol. Chem. 259:13857-13862.